Encompass Health Corp (AMEX:EHC) – Investment analysts at SunTrust Banks lifted their FY2020 EPS estimates for Encompass Health in a research report issued to clients and investors on Monday, April 29th. SunTrust Banks analyst D. Macdonald now anticipates that the company will post earnings per share of $3.93 for the year, up from their prior forecast of $3.92.
Separately, Zacks Investment Research lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Wednesday, January 9th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $79.00.
Encompass Health (AMEX:EHC) last issued its quarterly earnings data on Thursday, April 25th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.15. The company had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.12 billion. During the same quarter in the previous year, the business earned $0.93 earnings per share. The company’s revenue was up 7.5% on a year-over-year basis.
The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a dividend of $0.27 per share. The ex-dividend date was Friday, March 29th. This represents a $1.08 dividend on an annualized basis and a dividend yield of ∞.
In related news, Director Leo I. Higdon, Jr. acquired 1,000 shares of the company’s stock in a transaction that occurred on Thursday, March 7th. The shares were acquired at an average cost of $58.84 per share, for a total transaction of $58,840.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.60% of the company’s stock.
A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in Encompass Health by 2.2% in the 3rd quarter. Vanguard Group Inc. now owns 9,285,576 shares of the company’s stock valued at $723,811,000 after buying an additional 200,890 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Encompass Health by 1.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,433,372 shares of the company’s stock valued at $111,731,000 after buying an additional 21,766 shares during the last quarter. Morgan Stanley increased its stake in Encompass Health by 25.8% in the 3rd quarter. Morgan Stanley now owns 638,008 shares of the company’s stock valued at $49,731,000 after buying an additional 130,728 shares during the last quarter. AQR Capital Management LLC increased its stake in Encompass Health by 177.2% in the 3rd quarter. AQR Capital Management LLC now owns 70,264 shares of the company’s stock valued at $5,477,000 after buying an additional 44,915 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in Encompass Health by 13.6% in the 3rd quarter. Nordea Investment Management AB now owns 57,325 shares of the company’s stock valued at $4,468,000 after buying an additional 6,856 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Read More: What is the LIBOR?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.